Private Equity Firm, THL to Acquire Clinical Trial Site Network, Headlands Research from KKR
Lake Worth, FL. & New York, August 23, 2025 – Thomas H. Lee Partners (THL) has entered into a...
Advertisement
mRNA Patent Dispute Resolved: BioNTech, CureVac, and GSK Strike $370M Licensing Deal
August 8, 2025 — London, UK. BioNTech SE has reached an agreement with CureVac to receive a non-exclusive license...
Bio-Thera and STADA Expand Alliance with Biosimilars-Tocilizumab
August 22, 2025 — Bio-Thera Solutions and STADA Arzneimittel have announced the expansion of their biosimilars partnership to include...
FDA Recalls Frozen Shrimp Because of Possible Health Risk
August 21, 2025: The U.S. Food and Drug Administration (FDA) has issued a public health advisory cautioning against consumption,...
SmartAlpha’s Ultrasound AI Software Nerveblox Gains FDA 510(k) Approval
ANKARA, Türkiye, August 18, 2025 — SmartAlpha’s AI-powered software, Nerveblox, designed to assist clinicians performing ultrasound-guided regional anesthesia (“nerve...
TheraBreath Launches Alcohol-Free Fluoride Toothpaste with Clinical Benefits
EWING, N.J., August 19, 2025 — TheraBreath™, the best-selling alcohol-free mouthwash brand in the U.S., has introduced a new...
AbbVie Completes $2.1B Acquisition of Capstan Therapeutics, Advancing In Vivo CAR-T Innovation
NORTH CHICAGO, IL. and SAN DIEGO, CA, August 19, 2025 – AbbVie (NYSE: ABBV) and Capstan Therapeutics, Inc. (“Capstan”),...
Convoke Raises $8.6M Seed Round to Build AI OS for Biopharma
SOUTH SAN FRANCISCO, Calif., August 19, 2025 – Convoke, an AI-native operating system for the biopharmaceutical industry, today announced...
First Patient Dosed in Akeso’s Phase III Trial of Cadonilimab for Resectable Gastric Cancer
Hong Kong, August 20, 2025 — Akeso, Inc. (9926.HK) has announced the enrollment and dosing of the first patient...
FDA Approves Merck Animal Health’s BRAVECTO QUANTUM – First Once-Yearly Injection Flea & Tick Protection for Dogs
July 10, 2025 – The U.S. Food and Drug Administration (FDA) has approved BRAVECTO® QUANTUM (fluralaner for extended-release injectable...
Advertisement
